hotspot -WSS

hotspot

author：knowledge 2025-09-30 20:35:45 - browse：839

LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion.

The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue. Inhibrx has completed Phase 1 testing of the drug and is enrolling patients in a Phase 2 trial.

Inhibrx’s other drug candidates, including its line of cancer-targeting immunotherapies, will be portioned out into a new company that will continue to be called Inhibrx. Mark Lappe, the founder and CEO of Inhibrx, will lead the spun-out company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

hotspot

WSS

Humana CEO Bruce Broussard to step down in 2024

Cancer cells are shown to suck energy source from immune cells

The drug industry has found itself all alone in Washington

Peter Marks talks Operation Warp Speed for Rare Diseases

Better Therapeutics data on benefit with GLP

CDC marks new Covid

hotspot

hotspot

focus

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Moonlake's readout produced a cash windfall. Risks remain

What the Wegovy shortage looks like for doctors — and for patients

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wellcome Trust names Røttingen as its new CEO

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Amylyx ALS drug fails large clinical trial

entertainment

How to bring more disabled researchers into academia

IVF, abortion rights issues kick off Biden’s State of the Union

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Researchers CRISPR chickens in bid to protect them from bird flu

Amylyx ALS drug failure raises questions and concerns

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

hotspot

hotspot

hotspot

Wikipedia